Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 13/20 | 0.44 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7792525 | 0.84 | P2RX7 (0.45) | P2RX7NTRK1EPHX2HDAC3HDAC1 | |
| SCHEMBL5723612 | 0.73 | P2RX7 (0.57) | P2RX7NTRK1EPHX2HDAC3HDAC1 | |
| SCHEMBL16538118 | 0.70 | P2RX7 (0.57) | P2RX7NTRK1EPHX2HDAC3HDAC1 | |
| SCHEMBL4576232 | 0.70 | P2RX7 (0.55) | P2RX7NTRK1EPHX2HDAC3HDAC1 | |
| SCHEMBL16972742 | 0.70 | HDAC3 (0.55) | P2RX7NTRK1EPHX2HDAC3HDAC1 | |
| SCHEMBL6355300 | 0.69 | EPHX2 (0.55) | P2RX7NTRK1EPHX2HDAC3HDAC1 | |
| SCHEMBL16538163 | 0.68 | IDO1 (0.49) | P2RX7NTRK1EPHX2HDAC3HDAC1 | |
| SCHEMBL343998 | 0.68 | LMNA (0.43) | — | |
| SCHEMBL6355022 | 0.68 | EPHX2 (0.53) | P2RX7NTRK1EPHX2HDAC3HDAC1 | |
| SCHEMBL28438485 | 0.67 | EPHX2 (0.52) | EPHX2PPARGIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2428207-A1 | Alpha-2B adrenergic receptor agonist and serotonin-norepinephrine reuptake inhibitor compositions for treating chronic pain | Allergan, Inc. (US) | 2012-03-14 | — | — | EP | disclosed |